Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0001209191-23-036544

See Remarks sold 325,330 shares at an average $12.90 ($4,195,797)

  • See Remarks acquired 278,030 shares (option exercise)
  • See Remarks gave 21,800 shares (gift)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Brumm Joshua T See Remarks 2023-06-08 Gift −20,000 302,483 D
Brumm Joshua T See Remarks 2023-06-08 Gift −1,800 300,683 D
Brumm Joshua T See Remarks 2023-06-08 Option exercise +30,088 $1.03 $30,991 330,771 D
Brumm Joshua T See Remarks 2023-06-08 Sale −46,811 $13.15 $615,565 283,960 D
Brumm Joshua T See Remarks 2023-06-08 Sale −14,189 $13.47 $191,126 269,771 D
Brumm Joshua T See Remarks 2023-06-09 Option exercise +76,582 $1.03 $78,879 346,353 D
Brumm Joshua T See Remarks 2023-06-09 Sale −76,582 $13.34 $1,021,604 269,771 D
Brumm Joshua T See Remarks 2023-06-12 Option exercise +171,360 $1.03 $176,501 441,131 D
Brumm Joshua T See Remarks 2023-06-12 Sale −187,748 $12.61 $2,367,502 253,383 D
Derivatives
Brumm Joshua T See Remarks 2023-06-08 Option exercise · Stock Option (right to buy) −30,088 317,661 D
Brumm Joshua T See Remarks 2023-06-09 Option exercise · Stock Option (right to buy) −76,582 241,079 D
Brumm Joshua T See Remarks 2023-06-12 Option exercise · Stock Option (right to buy) −171,360 69,719 D
Open-market sales · 325,330 sh · avg $12.90 · $4,195,797
Loading xslF345X04/doc4.xml…